Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahmoud A Elshenawy

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Breast Care (Basel, Switzerland)|July 12, 2021
Ribociclib-Induced Pneumonitis: A Case ReportGhada Algwaiz, Ahmed Ali Badran, Mahmoud A Elshenawy, et al.
Immunotherapy|January 5, 2022
Peripheral blood eosinophil count is associated with response to chemoimmunotherapy in metastatic triple-negative breast cancerHazem Ghebeh, Mahmoud A Elshenawy, Adher D AlSayed, et al.
The American Journal of Case Reports|November 7, 2019
Complete Response of Chemo-Refractory Metastatic Metaplastic Breast Cancer to Paclitaxel-Immunotherapy CombinationAdher D Al Sayed, Mahmoud A Elshenawy, Asma Tulbah, et al.
Annals of Hematology|February 28, 2018
Survival analysis of patients with Hodgkin lymphoma who failed high dose chemotherapy and autologous stem cell transplantMahmoud A Elshenawy, M Shahzad Rauf, Tusneem A M Elhassan, et al.
Clinical Medicine Insights. Case Reports|December 11, 2023
Successful Recovery of COVID-19 Associated With Cardiomyopathy in Advanced Breast Cancer Patient With Pulmonary Lymphangitis CarcinomatosisHisham Alquaydheb, Abrar Alharbi, Ahmed Badran, et al.
JCO Global Oncology|February 8, 2020
Efficacy and Prognostic Factors of Sunitinib as First-Line Therapy for Patients With Metastatic Renal Cell Carcinoma in an Arab PopulationAhmed Badran, Mahmoud A Elshenawy, Amgad Shahin, et al.
Hereditary Cancer in Clinical Practice|February 10, 2021
Risk of hematological malignancies in the families of patients treated for nodular lymphocyte-predominant Hodgkin lymphomaSaad Akhtar, M Shahzad Rauf, Amani Al-Kofide, et al.
World Journal of Surgical Oncology|July 10, 2020
Survival benefit of surgical resection after first-line triplet chemotherapy and bevacizumab in patients with initially unresectable metastatic colorectal cancerMahmoud A Elshenawy, Ahmed Badran, Ali Aljubran, et al.
Molecular and Clinical Oncology|February 17, 2023
Characteristics and outcomes of small bowel adenocarcinoma: 14 years of experience at a single tertiary hospital in Saudi ArabiaBader Alshamsan, Mohamed Aseafan, Ahmed Badran, et al.
Cancer Management and Research|September 13, 2021
Real-World Outcome and Prognostic Factors of Pazopanib in Advanced Soft Tissue SarcomaBader Alshamsan, Ahmad Badran, Aisha Alshibany, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Breast Care (Basel, Switzerland)|July 12, 2021
Ribociclib-Induced Pneumonitis: A Case ReportGhada Algwaiz, Ahmed Ali Badran, Mahmoud A Elshenawy, et al.
Immunotherapy|January 5, 2022
Peripheral blood eosinophil count is associated with response to chemoimmunotherapy in metastatic triple-negative breast cancerHazem Ghebeh, Mahmoud A Elshenawy, Adher D AlSayed, et al.
The American Journal of Case Reports|November 7, 2019
Complete Response of Chemo-Refractory Metastatic Metaplastic Breast Cancer to Paclitaxel-Immunotherapy CombinationAdher D Al Sayed, Mahmoud A Elshenawy, Asma Tulbah, et al.
Annals of Hematology|February 28, 2018
Survival analysis of patients with Hodgkin lymphoma who failed high dose chemotherapy and autologous stem cell transplantMahmoud A Elshenawy, M Shahzad Rauf, Tusneem A M Elhassan, et al.
Clinical Medicine Insights. Case Reports|December 11, 2023
Successful Recovery of COVID-19 Associated With Cardiomyopathy in Advanced Breast Cancer Patient With Pulmonary Lymphangitis CarcinomatosisHisham Alquaydheb, Abrar Alharbi, Ahmed Badran, et al.
JCO Global Oncology|February 8, 2020
Efficacy and Prognostic Factors of Sunitinib as First-Line Therapy for Patients With Metastatic Renal Cell Carcinoma in an Arab PopulationAhmed Badran, Mahmoud A Elshenawy, Amgad Shahin, et al.
Hereditary Cancer in Clinical Practice|February 10, 2021
Risk of hematological malignancies in the families of patients treated for nodular lymphocyte-predominant Hodgkin lymphomaSaad Akhtar, M Shahzad Rauf, Amani Al-Kofide, et al.
World Journal of Surgical Oncology|July 10, 2020
Survival benefit of surgical resection after first-line triplet chemotherapy and bevacizumab in patients with initially unresectable metastatic colorectal cancerMahmoud A Elshenawy, Ahmed Badran, Ali Aljubran, et al.
Molecular and Clinical Oncology|February 17, 2023
Characteristics and outcomes of small bowel adenocarcinoma: 14 years of experience at a single tertiary hospital in Saudi ArabiaBader Alshamsan, Mohamed Aseafan, Ahmed Badran, et al.
Cancer Management and Research|September 13, 2021
Real-World Outcome and Prognostic Factors of Pazopanib in Advanced Soft Tissue SarcomaBader Alshamsan, Ahmad Badran, Aisha Alshibany, et al.
Pageof 3